Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
In the Solvadi advertisement I read, it stated cure* was achieved by taking Sovaldi with ribavirin and weekly injections of peginterferon alfa. So, does that mean Olysio takes the place of the riba and interferon and the same results are achieved? I was just wanting to know what you all thought....
http://www.hepmag.com/articles/Olysio_Sovaldi_2501_25501.shtml
"The American Association for the Study of Liver Diseases currently recommends 12 weeks of the NS3/4A protease inhibitor Olysio and the NS5B polymerase inhibitor Sovaldi plus ribavirin for the treatment of those people with genotype 1 of hep C who are ineligible to receive interferon. However, the combination is not currently approved by the FDA, so physicians must prescribe it off label. Gaining FDA approval would not only grant Janssen the permission to market Olysio as a part of this combination therapy, but would also allow ribavirin to be taken out of the mix."
http://www.hepmag.com/articles/Olysio_Sovaldi_FDA_2501_25561.shtml
It says ineligible for inteferon, but those who have failed interferon can also get it.... and proven anxiety or depression can make you ineligible for inf and eligible for S & O, depending on your insurance.
http://www.hepmag.com/articles/Olysio_Sovaldi_2501_25501.shtml.
These drugs are all very new but I remain confident it will prove to be a great treatment choice for geno 1s